Results · Apr-Jun 2026
Sanofi Consumer Healthcare India Q1 FY27 results
Sales grew 7% to ₹236 crore from ₹221 crore in Apr-Jun 2025.
Operating profit grew 27% to ₹89.3 crore, an operating margin of 37.9% (up 6.1 points from a year ago).
Net profit grew 13% to ₹68.8 crore from ₹60.7 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +3%, net profit +1%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 235.7 | 220.9 | +7% |
| Operating profit (EBITDA) | 89.3 | 70.2 | +27% |
| Operating margin | 37.9% | 31.8% | +6.1 pts |
| Net profit | 68.8 | 60.7 | +13% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 6 quarters
Sanofi Consumer Healthcare India calls this quarter Apr-Jun 2026. From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.